The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant

被引:20
作者
Losman, B
Biller, M
Olofsson, S
Schonning, K
Lund, OS
Svennerholm, B
Hansen, JES
Bolmstedt, A
机构
[1] Gothenburg Univ, Dept Clin Virol, S-41346 Gothenburg, Sweden
[2] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis 144, DK-2650 Hvidovre, Denmark
关键词
acquired immunodeficiency syndrome; U937; macrophage; human immunodeficiency virus type 1; carbohydrate;
D O I
10.1016/S0014-5793(99)00740-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that an N-glycosylation site of N306 of HIV-1 gp120 is not necessary for the HIV-1 infectivity but protects HIV-1 from neutralising antibodies, In contrast Nakayama et al, FEES Lett, (1998) 426, 367-372], using a virus with an identical V3 region, suggested that elimination of this particular glycan reduced the ability of T-tropic HIV to bind to CXCR4 and hence its ability to infect T cell lines, We therefore re-examined the ability of a mutant virus, lacking the N306 glycan, to replicate in various types of cells and found no change in co-receptor usage for mutant virus. The ability of mutant virus to replicate or to induce syncytia in infected cells was similar to that of wild type virus. These results corroborate our original observation, confirming that the induced mutation in the N306 glycosylation site neither impairs nor improves the ability of mutant virus to replicate in permissive cells. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 39 条
[1]   NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE [J].
ARENDRUP, M ;
SONNERBORG, A ;
SVENNERHOLM, B ;
AKERBLOM, L ;
NIELSEN, C ;
CLAUSEN, H ;
OLOFSSON, S ;
NIELSEN, JO ;
HANSEN, JES .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :855-863
[2]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[3]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[4]   Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response [J].
Bolmstedt, A ;
Sjolander, S ;
Hansen, JES ;
Akerblom, L ;
Hemming, A ;
Hu, SL ;
Morein, B ;
Olofsson, S .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 12 (03) :213-220
[5]   USE OF A NEW CD4-POSITIVE HELA-CELL CLONE FOR DIRECT QUANTITATION OF INFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS FROM BLOOD-CELLS OF AIDS PATIENTS [J].
CHESEBRO, B ;
WEHRLY, K ;
METCALF, J ;
GRIFFIN, DE .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :64-70
[6]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554
[7]   Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes [J].
Chesebro, B ;
Wehrly, K ;
Nishio, J ;
Perryman, S .
JOURNAL OF VIROLOGY, 1996, 70 (12) :9055-9059
[8]   Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4 [J].
Cho, MW ;
Lee, MK ;
Carney, MC ;
Berson, JF ;
Doms, RW ;
Martin, MA .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2509-2515
[9]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[10]   A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].
Doranz, BJ ;
Rucker, J ;
Yi, YJ ;
Smyth, RJ ;
Samson, M ;
Peiper, SC ;
Parmentier, M ;
Collman, RG ;
Doms, RW .
CELL, 1996, 85 (07) :1149-1158